Literature DB >> 28160848

Traditional preparations of kava (Piper methysticum) inhibit the growth of human colon cancer cells in vitro.

L S Einbond1, A Negrin2, D M Kulakowski2, H-A Wu3, V Antonetti4, F Jalees4, W Law5, M Roller6, S Redenti2, E J Kennelly2, M J Balick7.   

Abstract

BACKGROUND: Epidemiological studies indicate there is low incidence of colon cancer in the South Pacific islands, including Fiji, West Samoa, and Vanuatu. Cancer incidence has been shown to be inversely associated with kava (Piper methysticum G. Forst.) ingestion. Hypothesis/Purpose: Kava prepared traditionally will inhibit the growth of human cancer cells. This investigation entails preparation and analysis of kava extracts and study of the growth inhibitory activity of the extracts, alone and combined with hibiscus. STUDY
DESIGN: We will prepare kava as in Micronesia - as a water extract, high in particulate content, alone or combined with sea hibiscus (Hibiscus tiliaceus L.) - and examine the components and growth inhibitory activity.
METHODS: We obtained ground kava prepared in the traditional way from lateral roots and sea hibiscus mucilage and sap from different sources in Micronesia, and prepared water extracts (unfiltered, as well as filtered, since in traditional use the kava beverage contains a high particulate content) and partitions. We used the MTT assay to determine the growth inhibitory activity of the preparations on colon and breast cancer cells and nonmalignant intestinal epithelial cells. LC-MS analysis was used to examine the components of the kava and sea hibiscus extracts and partitions.
RESULTS: Traditional preparations of kava inhibit the growth of breast and colon cancer cells. Among the kava preparations, the order of decreasing activity was Fiji(2), Fiji(1), Hawaii; the unfiltered preparations from Fiji were more active than the filtered. Phytochemical analysis indicated that filtering reduced most kavalactone and chalcone content. For example, for Fiji(2), the ratio of dihydromethysticin in filtered/unfiltered kava was 0.01. Thus, for the extracts from Fiji, growth inhibitory activity correlates with the content of these compounds. Unfiltered and filtered kava from Fiji(1) were more active on malignant than nonmalignant intestinal epithelial cells. Since kava is prepared in Micronesia by squeezing the extract through sea hibiscus bark, we assayed the growth inhibitory activity of combinations of kava and sea hibiscus sap and found that sea hibiscus enhanced the growth inhibitory effect of kava.
CONCLUSION: Our results show that traditional kava, alone or combined with sea hibiscus, displays activity against human cancer cells and indicate it will be worthwhile to develop and further analyze these preparations to prevent and treat colon and other cancers. Our findings suggest it is important to examine the activity of plants in the form that people consume them.
Copyright © 2016 Elsevier GmbH. All rights reserved.

Entities:  

Keywords:  Chalcone; Hibiscus tiliaceus; Kavalactone; Malvaceae; Piper methysticum; Piperaceae

Mesh:

Substances:

Year:  2016        PMID: 28160848     DOI: 10.1016/j.phymed.2016.11.002

Source DB:  PubMed          Journal:  Phytomedicine        ISSN: 0944-7113            Impact factor:   5.340


  5 in total

Review 1.  An Updated Review on the Psychoactive, Toxic and Anticancer Properties of Kava.

Authors:  Rita B Soares; Ricardo Jorge Dinis-Oliveira; Nuno G Oliveira
Journal:  J Clin Med       Date:  2022-07-12       Impact factor: 4.964

2.  Inhibition of autophagy enhances synergistic effects of Salidroside and anti-tumor agents against colorectal cancer.

Authors:  Hai Li; Chen Chen
Journal:  BMC Complement Altern Med       Date:  2017-12-16       Impact factor: 3.659

Review 3.  Medicinal Plants in the Prevention and Treatment of Colon Cancer.

Authors:  Paola Aiello; Maedeh Sharghi; Shabnam Malekpour Mansourkhani; Azam Pourabbasi Ardekan; Leila Jouybari; Nahid Daraei; Khadijeh Peiro; Sima Mohamadian; Mahdiyeh Rezaei; Mahdi Heidari; Ilaria Peluso; Fereshteh Ghorat; Anupam Bishayee; Wesam Kooti
Journal:  Oxid Med Cell Longev       Date:  2019-12-04       Impact factor: 6.543

Review 4.  Kava as a Clinical Nutrient: Promises and Challenges.

Authors:  Tengfei Bian; Pedro Corral; Yuzhi Wang; Jordy Botello; Rick Kingston; Tyler Daniels; Ramzi G Salloum; Edward Johnston; Zhiguang Huo; Junxuan Lu; Andrew C Liu; Chengguo Xing
Journal:  Nutrients       Date:  2020-10-05       Impact factor: 5.717

Review 5.  Medicine in motion: Opportunities, challenges and data analytics-based solutions for traditional medicine integration into western medical practice.

Authors:  C Jansen; J D Baker; E Kodaira; L Ang; A J Bacani; J T Aldan; L M N Shimoda; M Salameh; A L Small-Howard; A J Stokes; H Turner; C N Adra
Journal:  J Ethnopharmacol       Date:  2020-10-21       Impact factor: 4.360

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.